Washington Trust CO Abb Vie Inc. Transaction History

Washington Trust CO

$2.83 Billion
Q3 2024

A detailed history of Washington Trust CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Washington Trust CO holds 30,016 shares of ABBV stock, worth $5.38 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

30,016

Previous 30,618 1.97%

Holding current value

$5.38 Million

Previous $5.25 Million 12.87%

% of portfolio

0.21%

Previous 0.19%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$163.84 - $199.33 $98,631 - $119,996	-602 Reduced 1.97%	30,016 $5.93 Million
Q2 2024 Jul 15, 2024	SELL	$154.79 - $180.76 $409,264 - $477,929	-2,644 Reduced 7.95%	30,618 $5.25 Million
Q1 2024 Apr 23, 2024	SELL	$159.82 - $182.1 $23,173 - $26,404	-145 Reduced 0.43%	33,262 $6.06 Million
Q4 2023 Jan 18, 2024	BUY	$137.6 - $154.97 $355,833 - $400,752	2,586 Added 8.39%	33,407 $5.18 Million
Q3 2023 Oct 18, 2023	SELL	$133.59 - $154.65 $13,359 - $15,465	-100 Reduced 0.32%	30,821 $4.59 Million
Q2 2023 Jul 27, 2023	SELL	$132.51 - $164.9 $74,603 - $92,838	-563 Reduced 1.79%	30,921 $4.17 Million
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $4.5 Million - $5.18 Million	31,126 Added 97268.75%	31,158 $4.97 Million
Q1 2023 May 04, 2023	SELL	$144.61 - $166.54 $4.55 Million - $5.24 Million	-31,452 Reduced 99.9%	32 $4.97 Million
Q4 2022 Jul 27, 2023	BUY	$138.31 - $165.87 $45,089 - $54,073	326 Added 1.05%	31,484 $5.09 Million
Q4 2022 Feb 08, 2023	SELL	$138.31 - $165.87 $174,547 - $209,327	-1,262 Reduced 3.85%	31,484 $5.09 Million
Q3 2022 Oct 14, 2022	SELL	$134.21 - $153.93 $83,612 - $95,898	-623 Reduced 1.87%	32,746 $4.4 Million
Q2 2022 Jul 25, 2022	BUY	$137.62 - $174.96 $48,304 - $61,410	351 Added 1.06%	33,369 $5.11 Million
Q1 2022 May 05, 2022	SELL	$131.98 - $163.75 $161,147 - $199,938	-1,221 Reduced 3.57%	33,018 $5.35 Million
Q4 2021 Feb 09, 2022	SELL	$107.43 - $135.93 $2.01 Million - $2.54 Million	-18,697 Reduced 35.32%	34,239 $4.64 Million
Q3 2021 Nov 09, 2021	SELL	$106.4 - $120.78 $101,931 - $115,707	-958 Reduced 1.78%	52,936 $5.71 Million
Q2 2021 Aug 05, 2021	BUY	$105.21 - $117.21 $229,463 - $255,635	2,181 Added 4.22%	53,894 $6.07 Million
Q1 2021 Apr 28, 2021	SELL	$102.3 - $112.62 $31,099 - $34,236	-304 Reduced 0.58%	51,713 $5.6 Million
Q4 2020 Feb 09, 2021	SELL	$80.49 - $108.67 $203,720 - $275,043	-2,531 Reduced 4.64%	52,017 $5.57 Million
Q3 2020 Nov 05, 2020	SELL	$85.91 - $100.83 $117,524 - $137,935	-1,368 Reduced 2.45%	54,548 $4.78 Million
Q2 2020 Aug 04, 2020	SELL	$73.37 - $98.18 $268,387 - $359,142	-3,658 Reduced 6.14%	55,916 $5.42 Million
Q1 2020 May 07, 2020	BUY	$64.5 - $97.79 $214,849 - $325,738	3,331 Added 5.92%	59,574 $4.54 Million
Q4 2019 Feb 12, 2020	BUY	$72.13 - $90.25 $1.17 Million - $1.46 Million	16,156 Added 40.3%	56,243 $4.98 Million
Q3 2019 Nov 06, 2019	SELL	$62.98 - $75.72 $231,892 - $278,801	-3,682 Reduced 8.41%	40,087 $3.19 Million
Q2 2019 Aug 07, 2019	SELL	$65.7 - $83.98 $163,067 - $208,438	-2,482 Reduced 5.37%	43,769 $3.18 Million
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $234,582 - $276,092	-3,041 Reduced 6.17%	46,251 $3.61 Million
Q4 2018 Feb 11, 2019	SELL	$77.85 - $96.01 $175,941 - $216,982	-2,260 Reduced 4.38%	49,292 $4.55 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $456,197 - $507,148	-5,131 Reduced 9.05%	51,552 $4.88 Million
Q2 2018 Aug 10, 2018	BUY	$89.78 - $106.23 $379,230 - $448,715	4,224 Added 8.05%	56,683 $5.25 Million
Q1 2018 May 10, 2018	SELL	$92.01 - $123.21 $401,623 - $537,811	-4,365 Reduced 7.68%	52,459 $4.97 Million
Q4 2017 Feb 05, 2018	SELL	$89.56 - $98.21 $373,286 - $409,339	-4,168 Reduced 6.83%	56,824 $5.5 Million
Q3 2017 Oct 31, 2017	BUY	$69.85 - $89.22 $4.26 Million - $5.44 Million	60,992	60,992 $5.42 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust CO with notifications on news.

Account

Washington Trust CO Abb Vie Inc. Transaction History